Biotech

All Articles

Former Seagen chief executive officer introduces brand-new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer in 2014 for an im...

Ironwood makes more bid for $1B GI drug with brand-new subgroup information

.On the heels of a phase 3 succeed that stopped working to impress capitalists, Ironwood Pharmaceuti...

Novartis inks $150M offer for autoimmune molecular glue

.Don't cease Monte Rosa Therapeutics right now. The Boston-based biotech is having a ball after auth...

Jade takes director staff along with Chinook vets-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable management hirings, shootings as well...

Septerna goes public with upsized offering of $288M

.Celebrating his provider's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer sounde...

AbbVie makes Richter wealthier, spending $25M to constitute discovery treaty

.AbbVie has actually come back to the source of its own antipsychotic giant Vraylar seeking one more...

GenSight gets into last full weeks of cash money path as revenue flow edges out of reach

.GenSight Biologics is actually weeks out of losing funds. Once more. The biotech merely has suffici...

AZ licenses disposed of unusual ailment medication to Monopar Rehabs

.Monopar Rehabs is actually bouncing back a medication from the dump of AstraZeneca's rare ailment p...

Arcus' new HIF-2a records in renal cancer hint at potential advantage over Merck's Welireg, professionals point out

.With new data out on Arcus Biosciences' experimental HIF-2a prevention, one group of analysts estim...

Roche bets approximately $1B to extend Dyno gene treatment distribution treaty

.After creating a genetics therapy relationship with Dyno Therapies in 2020, Roche is actually back ...